Top Markets
Coin of the day
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Rang in aandelen #40980
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Aandeelprijs
$0.14355401
Marktkapitalisatie
$55.27K
Verandering (1 dag)
-1.86%
Verandering (1 jaar)
1.06%
Land
VG
Handel CRISM Therapeutics Corporation (CRTX)

Categorie

Dividendrendementgeschiedenis voor CRISM Therapeutics Corporation (CRTX)
Het dividendrendement (TTM) van CRISM Therapeutics Corporation (aandelsymbool: CRTX) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van CRISM Therapeutics Corporation (CRTX) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten